Both in R&D — Physical & Biological Sciences
Medpace Holdings vs Incyte Genomics
Over the past year MEDP returned +10.5% and INCY returned +19.4%; their daily moves had a correlation of 0.28.
MEDP +10.5% INCY +19.4%Growth of $1, one year, split-adjusted
| Metric | MEDP | INCY |
|---|---|---|
| Price | $656.77 | $122.85 |
| Market cap | $18.37B | $25.04B |
| Today | −1.01% | +4.47% |
| 1 month | +8.9% | +9.0% |
| 6 months | +53.9% | +23.0% |
| Year to date | +16.9% | +24.4% |
| 1 year | +10.6% | +21.0% |
| Revenue growth (YoY) | +8.5% | +14.0% |
| Gross margin | 31.3% | 93.0% |
| Net margin | 19.2% | −50.4% |
| P/E (TTM) | 35.5× | 62.1× |
| Price / sales | 6.5× | 4.2× |
| Net cash | $705.3M | $3.82B |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 28.6% |
| Short % of float | 7.2% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).